Headache in Brain Tumors.
Brain tumor
Cancer
Diagnosis
Headache
Intracranial neoplasm
Pathophysiology
Treatment
Journal
Neurologic clinics
ISSN: 1557-9875
Titre abrégé: Neurol Clin
Pays: United States
ID NLM: 8219232
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
medline:
5
4
2024
pubmed:
5
4
2024
entrez:
4
4
2024
Statut:
ppublish
Résumé
The prevalence of brain tumors in patients with headache is very low; however, 48% to 71% of patients with brain tumors experience headache. The clinical presentation of headache in brain tumors varies according to age; intracranial pressure; tumor location, type, and progression; headache history; and treatment. Brain tumor-associated headaches can be caused by local and distant traction on pain-sensitive cranial structures, mass effect caused by the enlarging tumor and cerebral edema, infarction, hemorrhage, hydrocephalus, and tumor secretion. This article reviews the current findings related to epidemiologic details, clinical manifestations, mechanisms, diagnostic approaches, and management of headache in association with brain tumors.
Identifiants
pubmed: 38575261
pii: S0733-8619(23)00098-1
doi: 10.1016/j.ncl.2023.12.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
487-496Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure M.K. Chu was a site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and Ildong Pharmaceutical Company over the past 24 months. He has received grants from the Yonsei University College of Medicine (6–2021–0229), the Korea Health Industry Development Institute (KHIDI) (HVC22CO106), and the National Research Foundation of Korea grant from the Korean Government (MSIT) (2022R1A2C1091767).